Search for on  
Wednesday, January 07, 2009
     
 Home
 About CWA
 Join CWA
 Give/Donate
- Donate Now
- More Ways to Give
 Get Involved
- Federal
- State/Local
 Media Center
- CWA Experts
- Press Releases
- CWA In The News
- CWA Op/Eds
 Legislation
 Beverly LaHaye
 Institute
 Culture and Family Issues
 Legal Studies
 Family Voice
- Subscribe Online!
 Multimedia
 Shop CWA
 About CWA
 CWALAC
 Project 535
 Employment
 Internships
 Brochures
 Fact Cards
 Recently on CWA
 Links

 

CWA Says New RU-486 Study Proves Need for Drug’s Suspension      7/28/2005

Washington, D.C. – Concerned Women for America (CWA) called “insufficient” the Food and Drug Administration’s (FDA’s) recent decision to strengthen the language on RU-486’s warning label after reports that two more women have died after taking the abortion pill. Five women in the United States and Canada have died from septic shock after taking RU-486, or mifepristone.

“The FDA allows the death toll to mount and confesses to being ‘baffled’ by the deaths,” said Wendy Wright, CWA’s senior policy director. “Thanks to the hard work of Brown University professor Ralph P. Miech, MD, PhD, we may have the answer to why RU-486 causes harm to women as well as their babies.”

The Annals of Pharmacotherapy will publish Dr. Miech’s study in the September issue, which shows:

During an abortion, mifepristone works by blocking the effects of progesterone, shutting off nutrition to the placenta and fetus. However, Miech points out, the anti-progesterone effects of mifepristone also cause changes in the cervix that allow C. sordellii, a common vaginal bacteria, to enter the cervical canal. C. sordellii thrives in this low-oxygen environment and derives nutrition from the decaying fetal tissue. [Emphasis added.]

Mifepristone also disrupts the immune system, which “impairs the body’s ability to fight off C. sordellii and may help spread the bacteria’s toxic by-products, a combination that sometimes results in widespread septic shock.” The women don’t exhibit the usual warning signs of an infection, mainly, a fever.

“Last week’s FDA announcement on RU-486 mentioned the deaths linked to RU-486, but neglected to release information about near-fatal adverse events,” said Wright. Under the Freedom of Information Act (FOIA), CWA received public documents listing over 600 adverse events.

“Women trust that the FDA is doing its job to protect our health,” said Wright. “To continue this trust, the FDA should withdraw its approval of RU-486 before more women die.”

For Information Contact:
Valerie Mosher
(202) 488-7000
media.cwfa.org

Printer Friendly Version

Recent Articles
Announcing the 2009 Pro-Life Lobby Day on February 24
Obama Faces Pro-Life Opposition During Inauguration Week
HHS Issues Rule Protecting Rights of Choice and Conscience
Frozen Embryo Adoptions are Heating Up
Defunding Planned Parenthood in Kansas
Family Voice: Christmas 2008
HHS Rule Protects Patients’ Ability to Access Doctors of their Choice
Planned Parenthood Caught Again
New Gift Idea for Christmas 2008: Planned Parenthood of Indiana Offers Death by Gift Certificate
Abortion Advocates Emboldened by Obama Win

 

 
 

 

Concerned Women for America
1015 Fifteenth St. N.W., Suite 1100
Washington, D.C. 20005
Phone: (202) 488-7000
Fax: (202) 488-0806

Feedback / Questions? || Problem with this page? || Archives



 
    ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... .....